Device Trial Radar · NCT05730192
EAGLE Trial CADDIE Artificial Intelligence Endoscopy
Last checked: Nov 20, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
985
Actual
Start
May 10, 2023
Primary completion
Nov 20, 2023
Study completion Nov 29, 2023
Sponsor
- Lead sponsor
- Odin MedicalNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Meditrial Europe Ltd.
- First posted
- Feb 15, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The EAGLE study is a prospective randomized controlled multicenter parallel design trial, for the assessment of clinical performance of the CADDIE device and to confirm that the device performs as expected.
Conditions
- Colorectal Cancer
- Polyp of Colon
- Adenoma Colon
Interventions
Colonoscopy with CADDIEDevice
A standard colonoscopy is performed with real-time support of the computer-aided detection (CADe) device CADDIE, used to assist the endoscopist in the detection of colorectal lesions.
Standard ColonoscopyProcedure
A standard colonoscopy performed without the assistance of any computer-aided detection (CADe) system. Lesion detection relied solely on the endoscopist's visual assessment and clinical judgment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adenoma Per Colonoscopy (APC)Time frame: During the procedure
1 more outcomes with a free account
Locations
8 sites in 4 countries. Site status is shown where the registry gives one.
Sana Klinikum Lichtenberg
Berlin, Germany
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.